Prevention of secondary myocardial infarction
Degeorges, M.; Boissel, J.P.; Guermonprez, J.L.; Sultan, Y.; Weber, S.
La Semaine des Hopitaux Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 57(39-40): 1623-1625
1981
ISSN/ISBN: 0037-1777 PMID: 6119791 Document Number: 173564
Document emailed within 1 workday
Related Documents
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153Bergstrand, R.; Elmfeldt, D.; Hjalmarson, A.; Vedin, J.A.; Wilhelmsen, L.; Wilhelmsson, C. 1978: Secondary prevention after myocardial infarction Lakartidningen 75(20): 2038-2044
Mehta, R.H.; Eagle, K.A. 1998: Secondary prevention in acute myocardial infarction Bmj 316(7134): 838-842
Deedwania, P.C.; Carbajal, E.V. 1993: Secondary prevention after myocardial infarction. Too many choices, which ones work? Archives of Internal Medicine 153(3): 285-288
Smith, J.; Channer, K.S. 1995: Increasing prescription of drugs for secondary prevention after myocardial infarction Bmj 311(7010): 917-918
Taylor, S.H. 1996: Secondary prevention of myocardial infarction: new horizons for pharmacotherapy. Introduction European Heart Journal 17 Suppl F: 1-2
Sárosi, I.; Debreceni, G.; Mühl, D.; Kónyi, A.; Bogár, L.; Tekeres, M.; Tóth, K.; Habon, T.; Czopf, L.; Zámbó, K.; Schmidt, E. 1997: Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction Orvosi Hetilap 138(31): 1939-1945
Bichan, N.A.; Tepliakov, A.T. 2002: Effectiveness and safety of amlodipine in secondary prevention in patients with myocardial infarction Klinicheskaia Meditsina 80(1): 28-31
Válek, J.; Honzák, R.; Hammer, J.; Vondra, K.; Kauoká, J.; Stolz, I. 1980: Personality and attitudes of patients after myocardial infarction to provisions during secondary prevention Casopis Lekaru Ceskych 119(23-24): 665-668
Decorde, P. 1984: Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration Pharmatherapeutica 3(8): 515-525
Plak, Młgorzata.; Łobos, M.; Religa, W.; Tokarek, A.; Bonar, A.; Janas, B.; Paradowski, M. 2011: Evaluation of clinical usefulness of selected laboratory markers in the prediction of myocardial infarction in patients under secondary prevention Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 31(181): 9-14
Tachibana, E.; Watanabe, I.; Nagao, K.; Kanmatsuse, K. 2000: Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients Journal of Cardiology 35(4): 277-285
Willenheimer, R.; Erhardt, L.; Eskilsson, J. 1998: Heart failure after myocardial infarction: diagnosis, treatment, prevention. Echocardiography should be a routine procedure in myocardial infarction Lakartidningen 95(28-29): 3183-3187
Gurel, E.; Ozdemir, N.; Cevik, C.; Kaymaz, C. 2009: Acute anterior myocardial infarction secondary to a myocardial muscular bridge Journal of Invasive Cardiology 21(1): E12-E15
Rothfeld, E.L. 1971: Ventricular arrhythmias secondary to acute myocardial infarction Journal of the American Osteopathic Association 70(6): 600-601
Nand, N.; Singla, S.K.; Magu, S. 2017: Cardiac Abscess with Ventricular Aneurysm Secondary to Old Myocardial Infarction Journal of the Association of Physicians of India 65(5): 95-96
Rizzon, P.; Iliceto, S. 1994: Prevention of post-infarction remodelling with L-carnitine: multicenter study CEDIM (L-Carnitine digital echocardiography myocardial infarction) Cardiologia 39(12 Suppl. 1): 31-35
Corea, L.; Bentivoglio, M. 1989: Secondary prevention in the post-infarction period Cardiologia 34(2): 127-133
Tanahashi, N. 2014: Antiplatelet therapy for secondary prevention of cerebral infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 72(7): 1270-1275
Laurie, W. 1971: Prevention of myocardial infarction Medical Journal of Australia 1(7): 361-364